The Use of High Sensitivity C-Reactive Protein in Cardiovascular Disease Detection

Area of Science:

• Biomarkers
• Cardiovascular Medicine
• Inflammation Research

Background:

• Cardiovascular diseases (CVDs) are a leading cause of global mortality.
• Vascular inflammation, particularly atherosclerosis, is a primary driver of CVDs.
• Inflammatory biomarkers, such as C-reactive protein (CRP), are crucial for CVD detection and management.

Purpose of the Study:

• To highlight the role of C-reactive protein (CRP) as an inflammatory biomarker in cardiovascular diseases (CVDs).
• To emphasize the significance of high-sensitivity CRP (hsCRP) in assessing CVD prognosis, especially in intermediate-risk patients.
• To explore the potential of establishing hsCRP concentration thresholds for diagnosing acute cardiovascular events.

Main Methods:

• Review of existing literature on CRP and hsCRP as biomarkers for cardiovascular diseases.
• Analysis of hsCRP's role in atherosclerosis development, plaque instability, and clot formation.
• Discussion of hsCRP's utility in clinical settings for prognosis and potential diagnostic thresholds.

Main Results:

• C-reactive protein (CRP) is an acute phase protein and a mediator of atherosclerosis.
• High-sensitivity CRP (hsCRP) plasma concentration is utilized for CVD prognosis in intermediate-risk individuals.
• High hsCRP levels are positively associated with CVDs, including acute myocardial infarction, ischemic stroke, and hypertrophic cardiomyopathy.

Conclusions:

• High-sensitivity CRP (hsCRP) is a valuable biomarker for cardiovascular disease (CVD) risk stratification and prognosis.
• Establishing definitive hsCRP concentration limits could aid in the clinical diagnosis of acute cardiovascular conditions.
• Increased medical awareness of the hsCRP-CVD link is vital for improving patient survival and quality of life.